Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


17 noviembre 2014

Six month results demonstrate safety, effectiveness of VenaSeal

Interventional News

Covidien has announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal closure system in patients with chronic venous insufficiency (CVI) having symptomatic reflux in the great saphenous vein. The results were presented at American College of Phlebology Annual Congress (ACP 2014; Phoenix, USA).

11 diciembre 2014

Gore receives CE mark for Gore Viabahn Endoprosthesis

Interventional News

The Gore Viabahn Endoprosthesis has received CE mark approval to improve blood flow in symptomatic obstruction of peripheral veins, excluding the venae cavae and pulmonary veins.

10 diciembre 2014

Medtronic publishes latest Endurant AAA stent graft clinical study results

Interventional News

Medtronic has announced the latest results from two clinical studies analysing the performance of the Endurant AAA stent graft system. The Endurant system has been used to treat more than 165,000 patients worldwide since it was initially introduced in Europe in 2008, which according to a company press release, is more than any other device of its kind, being selected for nearly one of every two endovascular procedures to repair abdominal aortic aneurysms around the world.

08 diciembre 2014

ArtVentive Medical receives FDA clearance for EOS device

Interventional News

ArtVentive Medical has received US Food and Drug Administration (FDA) clearance for the Endoluminal Occlusion System (EOS). Designed for use in the peripheral vasculature, the EOS offers immediate, complete and total occlusion in arterial and venous settings.

23 octubre 2014

New deep vein thrombosis guidelines: What you need to know

Interventional News

Suresh Vedantham, professor of Radiology, Interventional Radiology Section, Washington University School of Medicine in St Louis, USA, spoke to Interventional News on the latest from the paper “Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal” hot on the heels of its online publication in the Journal of Vascular and Interventional Radiology (JVIR).

08 noviembre 2014

José Ignacio Bilbao Jaureguízar

Interventional News

“No matter what their future orientation, interventional radiologists involved in interventional oncology need to have a basic training in what is called ‘general interventional radiology’ in order to be able to provide a uniform and standardised care,” José Ignacio Bilbao Jaureguízar, professor and head of the Department of Interventional Radiology, Clínica Universitaria de Navarra, Pamplona, Spain, told Interventional News.

04 diciembre 2014

Too early to say that renal denervation is a failed therapy

Interventional News

In a new consensus statement, the Joint UK Societies claim that the negative results of SYMPLICITY HTN-3 should not be used as a “rationale for abandoning” renal denervation as a “novel therapeutic development” for resistant hypertension because they claim more clinical trials are needed to evaluate the safety and efficacy of the therapy.

03 diciembre 2014

Early results suggest Lithoplasty may be effective in the treatment of calcified peripheral lesions

Interventional News

Results of the DISRUPT PAD study show that Lithoplasty, a new balloon-based technology, demonstrates safety and efficacy in the treatment of superficial femoral artery and popliteal artery disease. Early results with the technology were presented at a late-breaking trial session at the Vascular Interventional Advances conference (VIVA, 4­–7 November, Las Vegas, USA).

28 diciembre 2014

Silk Road Medical unveils data from the ROADSTER trial

Interventional News

Silk Road Medical’s 30-day outcomes from the ROADSTER IDE study were presented at the Late Breaking Clinical Trials Session at the 2014 Vascular InterVentional Advances (VIVA) Meeting in Las Vegas, with additional data presented at the VEITHsymposium in New York.

24 noviembre 2014

Seven filter manufacturers to participate in study predicting effectiveness of inferior vena cava filters

Interventional News

The first large-scale, multispecialty prospective clinical research trial to evaluate the use of inferior vena cava (IVC) filters and related follow-up treatment in the USA – initiated by a collaboration between the Society of Interventional Radiology (SIR) and the Society for Vascular Surgery (SVS) – is set to enrol the first patient in spring 2015 with participation from seven filter manufacturers.

14 noviembre 2014

CeloNova gets US FDA approval for clinical trial with Oncozene

Interventional News

CeloNova BioSciences has announced that the US FDA has granted approval to start an investigational device exemption (IDE) clinical trial for its Oncozene embolic microspheres, loaded with doxorubicin, a chemotherapy drug used in the treatment of hepatocellular carcinoma.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.